Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus

Journal of Hepatology

Volumn 25, Issue 5, 1996, Pages 763-768

  Berg, Thomas ^a   Dirla, Ullrike ^a   Naumann, Uta ^a   Heuft, Hans Gerd ^a   Küther, Stefan ^a   Lobeck, Hartmut ^b   Schreier, Eckart ^a   Hopf, Uwe ^a,b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

GB virus C; Helicase region; Hepatitis C virus; Hepatitis G virus; Interferon alpha

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0030297336     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80250-9     Document Type: Article

References (10)

1. 1. Simons JN, Leary TP, Dawson, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar D, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
2. 2. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-7.
3. 3. Linnen J, Wages Jr J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW-K, Young L, Piatak Jr M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
4. 4. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-6.
5. 5. Schreier E, Höhne M, Künkel U, Berg T, Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany. J Hepatol 1996; in press.
6. 6. Knodell, RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
7. 7. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
8. 8. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
9. 9. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobsen IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989; 321: 1501-6.
10. 10. Kekulé AS, Nitschko H, Frösner G, Zachoval R, Brödl U, Mairhofer H, Schmalzbauer E. Hepatitis GB virus: coinfection with HCV, response to interferon and possible association with fulminant hepatitis. IX. Triennial International Symposium on Viral Hepatitis and Liver Disease. Rome 1996; 143 [Abstract].